Rate of Change of HbA1c (dx/dt) May Predict Progression to Type 2 DM

Rate of Change of HbA1c (dx/dt) May Predict Progression to Type 2 DM: Comparing the Concept of dx/dt With QD Diabetes Prediction Model. D.E.R.M.S Initiative (Doctor Enabled Risk Management System)

The investigators hypothesize that the HbA1c shows a rising trend in pre-diabetics and normal population with risk factors of developing type 2 DM. There is no known diabetes model for predicting incident diabetes in an individual which takes into account the rate of change of HbA1c (dx/dt). In such cases, the rate of change of HbA1c may give the physicians lead time needed to implement the Diabetes Prevention Program measures.

Inclusion Criteria:

• No self-reported history of diabetes or pre-diabetes defined as per ADA criteria
• Age greater than 18 years
• Scheduled to receive HbA1c in participating clinic
• Able and willing to give legally effective consent
• Able and willing to participate in patient questionnaires(attached)

Exclusion Criteria:

• Previously or currently taking medications for lowering glucose (i.e., exenatide, pramlintide, metformin, rosiglitazone, pioglitazone, or future diabetes drugs) based on self-report and/or prescreening. Patients on drugs causing hyperglycemia like Oral Steroids will be excluded.
• Baseline HbA1c level above 5.7
• Severe Anemia (defined as Hb less than 8gm/dL)
• Patients with hemoglobinopathies
• Pregnancy
• Polycystic ovarian disease